✨ Your Portfolio is fetched and updated from zerodha.
Micro
Market Cap
₹1,061 Cr.
P/E
36.48

Key Ratios

Market cap
Market cap
1,061 Cr
PE
PE
36.48
Prom Holding
Prom Holding
70.85 %
ROE (%)
ROE (%)
24.80
ROCE (%)
ROCE (%)
30.21
Div Yield (%)
Div Yield (%)
-
Sales
Sales
-
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
0.13
About
Remus Pharmaceuticals Limited is a company focusing on the marketing and distribution of finis… Read more
Low
935
52W Range
High
1282
  • Remus Pharmaceutical
  • Oswal Agro Mills
  • Uniphos Enterprises

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Remus Pharmaceuticals Ltd. Business

Remus Pharmaceuticals Limited is involved in marketing, distributing pharmaceutical formulations and APIs. It offers technical consultancy services to distributors and aims to build lasting relationships globally.

Remus Pharmaceutical major competitors are Oswal Agro Mills, Uniphos Enterprises, A-1, Vasa Denticity, Veritas (India), Hexa Tradex, Aeroflex Enterprises.
Market Cap of Remus Pharmaceutical is ₹1,061 Crs.
While the median market cap of its peers are ₹1,017 Crs.

Remus Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Remus Pharmaceutical is 5.61 and is ranked 5 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material